NCT06501638View on ClinicalTrials.gov

Efficacy and Safety of memanTine in the Treatment Of Frequently symPtomatic Atrial Premature Beats

NACompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

July 7, 2024

Primary Completion Date

June 29, 2025

Study Completion Date

June 29, 2025

Conditions
Atrial Premature Beats, Contractions, or Systoles
Interventions
DRUG

Memantine Hydrochloride 10 MG

Take Memantine Hydrochloride for intervention First week, 5mg(half the tablet), p.o.，bid. Second to Sixth week, 10mg(one tablet), p.o., bid

DRUG

Placebo

Take placebo for intervention First week, half the tablet, p.o., bid. Second to Sixth week, one tablet, p.o., bid

Trial Locations (1)

200120

Shanghai East Hospital, Shanghai

All Listed Sponsors
lead

Shanghai East Hospital

OTHER

NCT06501638 - Efficacy and Safety of memanTine in the Treatment Of Frequently symPtomatic Atrial Premature Beats | Biotech Hunter | Biotech Hunter